A Phase II Study of S‐1 and Paclitaxel Combination Therapy as a First‐Line Treatment in Elderly Patients with Advanced Non‐Small Cell Lung Cancer

Conclusion.This S‐1 and PTX cotherapy dose and schedule showed satisfactory efficacy with mild toxicities in elderly patients with advanced NSCLC.

Source: The Oncologist - April 10, 2019 Category: Cancer & Oncology Authors: Akihiro Yoshimura, Yusuke Chihara, Koji Date, Nobuyo Tamiya, Yoshizumi Takemura, Tatsuya Imabayashi, Yoshiko Kaneko, Tadaaki Yamada, Mikio Ueda, Taichiro Arimoto, Junji Uchino, Yoshinobu Iwasaki, Koichi Takayama Tags: Lung Cancer, Chinese Edition, Clinical Trial Results Source Type: research